Clinical Trial Update: Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating pioglitazone in patients with type 2 diabetes mellitus and covid-19 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED